{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:40:05Z","timestamp":1786534805196,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,10]]},"group-title":"Health Economics","reference-count":58,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. National Institute of Health","award":["R01AI149339"],"award-info":[{"award-number":["R01AI149339"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\n                    Curable sexually transmitted infections (STIs) are associated with adverse birth outcomes, yet little cost-effectiveness evidence guides antenatal STI screening policy in high-burden settings. We conducted a cost-effectiveness and cost-utility analysis of the Philani Ndiphile trial in South Africa, comparing One-Time and Two-Time antenatal screening for\n                    <jats:italic>C. trachomatis, N. gonorrhoeae,<\/jats:italic>\n                    and\n                    <jats:italic>T. vaginalis<\/jats:italic>\n                    with standard syndromic management.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A decision-analytic model from the provider perspective simulated costs and outcomes for pregnant women and infants. Costs included diagnostics, treatment, and neonatal hospitalisation for a primary composite outcome of preterm birth and\/or low birthweight and its components (secondary trial outcomes). Modelled outcomes included incremental cost (US$) per composite (preterm birth and\/or low birthweight) case, per component case and per disability-adjusted life year (DALY) averted. The analysis captured infant outcomes in the first year. Univariate and probabilistic sensitivity analyses were conducted to assess parameter uncertainty and robustness of results.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Screening for\n                    <jats:italic>C. trachomatis, N. gonorrhoeae,<\/jats:italic>\n                    and\n                    <jats:italic>T. vaginalis<\/jats:italic>\n                    twice during pregnancy was not cost-effective for preventing the primary composite outcome, nor for preventing low birthweight alone. However, two-time screening was cost-saving for preventing preterm birth alone, averting more DALYs and thereby yielding better health outcomes while reducing healthcare costs compared with syndromic management. One-time screening was not cost-effective for preventing any outcome.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\n                    Repeat antenatal screening for\n                    <jats:italic>C. trachomatis, N. gonorrhoeae<\/jats:italic>\n                    ,\n                    <jats:italic>and T. vaginalis<\/jats:italic>\n                    has the potential to prevent preterm births while reducing healthcare costs in high-burden settings. These findings support further research to confirm the clinical effectiveness of repeat screening and to evaluate longer-term health and economic impacts.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.08.08.26360003","type":"posted-content","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:55:14Z","timestamp":1786395314000},"source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness and cost-utility of antenatal sexually transmitted infection screening to reduce preterm birth and low birthweight in South Africa"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-7732","authenticated-orcid":false,"given":"Elise","family":"Smith","sequence":"first","affiliation":[{"name":"University of Cape Town, Health Economics Unit, School of Public Health, Faculty of Health Sciences, Cape Town, Western Cape, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3762-1620","authenticated-orcid":false,"given":"Chibuzor M","family":"Babalola","sequence":"additional","affiliation":[{"name":"University of Southern California, Department of Population and Public Health Sciences, Keck School of Medicine, Los Angeles, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Medina-Marino","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Department of Psychiatry, Perelman School of Medicine Philadelphia, PA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-0343","authenticated-orcid":false,"given":"Mandisa","family":"Mdingi","sequence":"additional","affiliation":[{"name":"Foundation for Professional Development, East London, Eastern Cape, ZA"},{"name":"University of Pretoria, Department of Medical Microbiology, Pretoria, Gauteng, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-1379","authenticated-orcid":false,"given":"Freedom","family":"Mukomana","sequence":"additional","affiliation":[{"name":"Foundation for Professional Development, East London, Eastern Cape, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-8986","authenticated-orcid":false,"given":"Nicola","family":"Low","sequence":"additional","affiliation":[{"name":"Universit\u00e4t Bern, Institute of Social and Preventive Medicine, Bern, CH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-9559","authenticated-orcid":false,"given":"Amarech","family":"Obse","sequence":"additional","affiliation":[{"name":"University of Cape Town, Health Economics Unit, School of Public Health, Faculty of Health Sciences, Cape Town, Western Cape, ZA"},{"name":"University of Greenwich, The Institute for Lifecourse Development, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-7275","authenticated-orcid":false,"given":"Remco P.H.","family":"Peters","sequence":"additional","affiliation":[{"name":"Foundation for Professional Development, East London, Eastern Cape, ZA"},{"name":"University of Pretoria, Department of Medical Microbiology, Pretoria, Gauteng, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Klausner","sequence":"additional","affiliation":[{"name":"University of Southern California, Department of Population and Public Health Sciences, Keck School of Medicine, Los Angeles, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-7958","authenticated-orcid":false,"given":"Susan","family":"Cleary","sequence":"additional","affiliation":[{"name":"University of Cape Town, Health Economics Unit, School of Public Health, Faculty of Health Sciences, Cape Town, Western Cape, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-0848","authenticated-orcid":false,"given":"Edina","family":"Sinanovic","sequence":"additional","affiliation":[{"name":"University of Cape Town, Health Economics Unit, School of Public Health, Faculty of Health Sciences, Cape Town, Western Cape, ZA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026081204151097000_2026.08.08.26360003v1.1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-055057"},{"key":"2026081204151097000_2026.08.08.26360003v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00448-5"},{"key":"2026081204151097000_2026.08.08.26360003v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-053999"},{"key":"2026081204151097000_2026.08.08.26360003v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054653"},{"key":"2026081204151097000_2026.08.08.26360003v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16774"},{"key":"2026081204151097000_2026.08.08.26360003v1.6","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & Trends in Child Mortality: Report 2024. Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. New York: United Nations Children\u2019s Fund, 2025."},{"key":"2026081204151097000_2026.08.08.26360003v1.7","unstructured":"World Health Organization. The Global Health Observatory. 2020. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO."},{"key":"2026081204151097000_2026.08.08.26360003v1.8","unstructured":"World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. 2021 https:\/\/pubmed.ncbi.nlm.nih.gov\/34370424\/."},{"key":"2026081204151097000_2026.08.08.26360003v1.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03573-3"},{"key":"2026081204151097000_2026.08.08.26360003v1.10","doi-asserted-by":"publisher","DOI":"10.1177\/0956462417724908"},{"key":"2026081204151097000_2026.08.08.26360003v1.11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3946862"},{"key":"2026081204151097000_2026.08.08.26360003v1.12","first-page":"1","article-title":"Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections\u202f: Moving towards best practice","volume":"23","year":"2022","journal-title":"South Afr J HIV Med"},{"key":"2026081204151097000_2026.08.08.26360003v1.13","unstructured":"World Health Organization. Guidelines for the management of asymptomatic sexually transmitted infections. Geneva, 2025."},{"key":"2026081204151097000_2026.08.08.26360003v1.14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/0956462416660483","article-title":"Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis","volume":"28","year":"2017","journal-title":"Int J STD AIDS"},{"key":"2026081204151097000_2026.08.08.26360003v1.15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/OLQ.0000000000002100","article-title":"Antenatal Screening for Sexually Transmitted Infections to Improve Maternal and Newborn Outcomes: An Update From 11 Low- and Middle-Income Countries","volume":"52","year":"2025","journal-title":"Sex. Transm. Dis"},{"key":"2026081204151097000_2026.08.08.26360003v1.16","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001258"},{"key":"2026081204151097000_2026.08.08.26360003v1.17","doi-asserted-by":"publisher","DOI":"10.7189\/JOGH.13.04058"},{"key":"2026081204151097000_2026.08.08.26360003v1.18","doi-asserted-by":"publisher","DOI":"10.64898\/2026.04.15.26350805"},{"key":"2026081204151097000_2026.08.08.26360003v1.19","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06400-y"},{"key":"2026081204151097000_2026.08.08.26360003v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249644"},{"key":"2026081204151097000_2026.08.08.26360003v1.21","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.13.24319006"},{"key":"2026081204151097000_2026.08.08.26360003v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2025-056488"},{"key":"2026081204151097000_2026.08.08.26360003v1.23","unstructured":"Department of Health. National Integrated Maternal and Perinatal Care Guidelines for South Africa. 5th Edition, 2024."},{"key":"2026081204151097000_2026.08.08.26360003v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"2026081204151097000_2026.08.08.26360003v1.25","unstructured":"South African Reserve Bank. Key Statistics. Selected Historical Rates. Rand per US Dollar. 2024. https:\/\/www.resbank.co.za\/en\/home\/what-we-do\/statistics\/key-statistics\/selected-historical-rates (accessed Sept 23, 2025)."},{"key":"2026081204151097000_2026.08.08.26360003v1.26","unstructured":"Department of Statistics South Africa (Stats SA). P0141 - Consumer Price Index (CPI), CPI History. 2024 https:\/\/www.statssa.gov.za\/?page_id=1854&PPN=P0141&SCH=73835 (accessed Sept 23, 2025)."},{"key":"2026081204151097000_2026.08.08.26360003v1.27","unstructured":"Department of Health. Guidelines for Pharmacoeconomic Submissions. Government Gazette. 2012."},{"key":"2026081204151097000_2026.08.08.26360003v1.28","first-page":"22","article-title":"Cost-minimisation analysis versus cost-effectiveness analysis, revisited","volume":"22","year":"2013","journal-title":"Health Economics (United Kingdom)"},{"key":"2026081204151097000_2026.08.08.26360003v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/16.3.326"},{"key":"2026081204151097000_2026.08.08.26360003v1.30","unstructured":"Mathers CD , Bernard C , Iburg KM , et al. Global Burden of Disease in 2002: data sources, methods and results. 2003 www.who.int\/evidence\/bod."},{"key":"2026081204151097000_2026.08.08.26360003v1.31","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease. Results Tool. https:\/\/vizhub.healthdata.org\/gbd-results\/. 2021."},{"key":"2026081204151097000_2026.08.08.26360003v1.32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(13)60993-9","article-title":"Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: A pooled country analysis","volume":"382","year":"2013","journal-title":"The Lancet"},{"key":"2026081204151097000_2026.08.08.26360003v1.33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.14132","article-title":"Replacing iron-folic acid with multiple micronutrient supplements among pregnant women in Bangladesh and Burkina Faso: costs, impacts, and cost-effectiveness","volume":"1444","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"2026081204151097000_2026.08.08.26360003v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4"},{"key":"2026081204151097000_2026.08.08.26360003v1.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001545"},{"key":"2026081204151097000_2026.08.08.26360003v1.36","doi-asserted-by":"crossref","unstructured":"Price JT , Wheeler SB , Stranix-Chibanda L , et al. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa. J Acquir Immune Defic Syndr (1988) 2016; : S145\u201353.","DOI":"10.1097\/QAI.0000000000001063"},{"key":"2026081204151097000_2026.08.08.26360003v1.37","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2214-109X(20)30395-8","article-title":"Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026081204151097000_2026.08.08.26360003v1.38","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000085"},{"key":"2026081204151097000_2026.08.08.26360003v1.39","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052367"},{"key":"2026081204151097000_2026.08.08.26360003v1.40","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-024-02234-1"},{"key":"2026081204151097000_2026.08.08.26360003v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2020.03.004"},{"key":"2026081204151097000_2026.08.08.26360003v1.42","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-026-04428-9"},{"key":"2026081204151097000_2026.08.08.26360003v1.43","unstructured":"Cepheid, Sunnyvale, CA, USA. 2024."},{"key":"2026081204151097000_2026.08.08.26360003v1.44","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10068-8"},{"key":"2026081204151097000_2026.08.08.26360003v1.45","unstructured":"Department of Health. Health Master Product List. https:\/\/www.health.gov.za\/tenders\/. 2024."},{"key":"2026081204151097000_2026.08.08.26360003v1.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002781"},{"key":"2026081204151097000_2026.08.08.26360003v1.47","first-page":"35","article-title":"Cost of intensive care services at a central hospital in south africa","volume":"109","year":"2019","journal-title":"South African Medical Journal"},{"key":"2026081204151097000_2026.08.08.26360003v1.48","unstructured":"Health Systems Trust. District Health Barometer 2023\/24. 2025."},{"key":"2026081204151097000_2026.08.08.26360003v1.49","unstructured":"Behrman RE , Butler AS . Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Preterm Birth: Causes, Consequences, and Prevention. National Academies Press, 2007."},{"key":"2026081204151097000_2026.08.08.26360003v1.50","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-2155-9"},{"key":"2026081204151097000_2026.08.08.26360003v1.51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/heapol\/czz152","article-title":"Estimating a cost-effectiveness threshold for health care decision-making in South Africa","volume":"35","year":"2020","journal-title":"Health Policy Plan"},{"key":"2026081204151097000_2026.08.08.26360003v1.52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jval.2021.08.014","article-title":"The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review","volume":"25","year":"2022","journal-title":"Value in Health"},{"key":"2026081204151097000_2026.08.08.26360003v1.53","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/18.2.86"},{"key":"2026081204151097000_2026.08.08.26360003v1.54","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.026930"},{"key":"2026081204151097000_2026.08.08.26360003v1.55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218349"},{"key":"2026081204151097000_2026.08.08.26360003v1.56","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2214-109X(24)00004-4","article-title":"Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea","volume":"12","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026081204151097000_2026.08.08.26360003v1.57","unstructured":"World Bank. Current health expenditure per capita (US$). South Africa. 2023. 2025; published online Dec 12. https:\/\/data.worldbank.org\/indicator\/SH.XPD.CHEX.PC.CD?locations=ZA."},{"key":"2026081204151097000_2026.08.08.26360003v1.58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/OLQ.0000000000001517","article-title":"Bridging the Gap between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections from Botswana","volume":"49","year":"2022","journal-title":"Sex Transm Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.08.08.26360003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:15:23Z","timestamp":1786533323000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.08.08.26360003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":58,"URL":"https:\/\/doi.org\/10.64898\/2026.08.08.26360003","relation":{},"subject":[],"published":{"date-parts":[[2026,8,10]]},"subtype":"preprint"}}